1Smith DS,Catalona WJ,Herschman JD.Longitudinal screening for prostate cancer with prostate-specific antigen.JAMA,1996,276:1309-1315.
2Uzzo RG,Pinover WH,Horwitz EM.Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digital rectal examination.Urology,2003,61:754-759.
3Ito K,Yamamoto T,Ohi M.Usefulness of prostate-specific antigen velocity in screening for prostate cancer.Int J Urol,2002,9:316-321.
4Hodge KK,McNeal JE,Terris MK,et al.Random systematic versus directed ultrasound guided transrectal core biopsy cores of the prostate.J Urol,1989,142:71-74.
5Presti JC,James Jr,Chang J,et al.The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies:results of a prospective clinical trial.J Urol,2000,163:163-166.
6Philip J,Ragavan N,Desouza J,et al.Effect of peripheral biopsies in maximizing early prostate cancer detection in 8-,10- or 12-core biopsy regimens.BJU Int,2004,93:1218 -1220.
7Bauer JJ,Jian CZ,James W,et al.Three-dimensional computer-simulated prostate models:lateral prostate biopsies increase the detection rate of prostate cancer.Urology,1999,53:961-967.
8Villers A,Mouton D,Rebillard X,et al.Biopsy technique and biopsy schemes for a first series of prostatic biopsies.Prog Urol,2004,14:144-153.
9Presti JC,Gerard JR,Odowd J,et al.Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates:results of a community multi-practice study.J Urol,2003,169:125-129.
